BBIO ์ต์ ๋ถ๊ธฐ ์์ต
๋ฐํ ๋ ์ง8/10/2026
EPS ์ค์ (๋ฏธ๊ตญ ๋ฌ๋ฌ)-0.78
์์ต ์ค์ (๋ฏธ๊ตญ ๋ฌ๋ฌ)243.68M
BridgeBio Pharma Inc ์ค์ ๋ฐํ ๋ ์ง ๋ฐ ๋ณด๊ณ ์
์ด ํ์ด์ง๋ ์ต์ BridgeBio Pharma Inc ์์ต ๋ณด๊ณ ์, ๋ค๊ฐ์ค๋ BridgeBio Pharma Inc ์ค์ ๋ฐํ ๋ ์ง, ๊ณผ๊ฑฐ ๋ฐ์ดํฐ ๋ฐ BridgeBio Pharma Inc ์ค์ ๋ฐํ ์ปจํผ๋ฐ์ค ๋ด์ค๋ฅผ ํฌํจํ ์์ธํ BridgeBio Pharma Inc ์์ต ๋ฐ์ดํฐ๋ฅผ ์ ๊ณตํฉ๋๋ค.
BBIO ํฅํ ๋ถ๊ธฐ ์ค์
๋ฐํ ๋ ์ง--
EPS ์์(๋ฏธ๊ตญ ๋ฌ๋ฌ)--
์์ต ์์(๋ฏธ๊ตญ ๋ฌ๋ฌ)--
BBIO FY2025 ์์ต
์ฐ๊ฐ ์ฃผ๋น์์ด์ต ์ฑ์ฅ๋ฅ (YoY)-3.79-31.46%
์ฐ๊ฐ ๋งค์ถ ์ฑ์ฅ๋ฅ (YoY)502.08M126.26%
BridgeBio Pharma Inc(BBIO) ์ค์ ๋ด์ญ
| ๋ฐํ์ผ | ๊ธฐ๊ฐ ์ข ๋ฃ | EPS/์์ | ์์ต/์์ | EPS ์ํ๋ผ์ด์ฆ % | ์์ต ์ํ๋ผ์ด์ฆ % |
|---|---|---|---|---|---|
| 8/10/2026 | 06/2026 | -0.78/-0.58 | 243.68M/218.74M | -33.25% | 11.40% |
| 5/7/2026 | 03/2026 | -0.84/-0.68 | 194.51M/177.94M | -24.11% | 9.32% |
| 2/24/2026 | 12/2025 | -1.00/-0.74 | 154.18M/146.84M | -34.25% | 4.99% |
| 10/29/2025 | 09/2025 | -0.95/-0.89 | 120.70M/106.39M | -7.18% | 13.45% |
| 8/5/2025 | 06/2025 | -0.95/-0.84 | 110.56M/91.41M | -13.22% | 20.96% |
| 4/29/2025 | 03/2025 | -0.88/-0.92 | 116.63M/61.94M | 4.64% | 88.30% |
| 2/20/2025 | 12/2024 | -1.40/-1.13 | 5.88M/3.48M | -23.71% | 69.05% |
| 11/12/2024 | 09/2024 | -0.86/-0.98 | 2.73M/3.76M | 12.16% | -27.37% |